H35.052
Retinal neovascularization, unspecified, left eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinal neovascularization refers to the abnormal growth of new blood vessels in the retina, the light-sensitive tissue at the back of the eye. When this process occurs without specifying the cause, it is classified under ICD-10 code H35.052, indicating the condition affects the left eye. This abnormal vessel growth can lead to serious complications such as bleeding, scarring, and vision loss if not properly managed. Understanding the condition, its causes, symptoms, and potential treatments can help in early detection and management, preserving vision and eye health.
Causes & Symptoms
Clinical Causes: Diabetic retinopathy, especially in its proliferative stage Retinal vein occlusion Inflammatory eye diseases Age-related macular degeneration Retinal detachment or injury Other systemic vascular conditions
Key Symptoms: Sudden or gradual loss of vision in the affected eye Blurred or distorted vision Floaters or dark spots in the vision field Visual disturbances such as shadow or curtain effect No noticeable symptoms in early stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis of retinal neovascularization involves a comprehensive eye examination by an eye care professional, including dilated fundus examination. Additional tests may include fluorescein angiography to visualize blood vessels and confirm abnormal growth, optical coherence tomography (OCT) to assess retinal structure, and other imaging modalities as required. Accurate diagnosis helps determine the underlying cause and guides appropriate management strategies.
Treatment Protocols: Treatment options aim to prevent further vessel growth, reduce visual impairment, and address the underlying cause. They may include: - Laser photocoagulation therapy: using laser to target and ablate abnormal vessels. - Intravitreal injections: medications such as anti-VEGF agents to inhibit abnormal blood vessel growth. - Steroid injections: to reduce inflammation associated with certain conditions. - Managing underlying systemic conditions: controlling blood sugar levels in diabetes, treating hypertension or other vascular issues. - Surgical procedures: in advanced cases involving significant bleeding or membrane formation. Early intervention is essential to preserve vision and prevent complications associated with retinal neovascularization.
Clinical Advice & FAQs
Billing Guidance
Is H35.052 a billable ICD-10 code?
Yes, H35.052 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.052?
Clinical documentation must specify the nature of Retinal neovascularization, unspecified, left eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference